183490.KQ
Price:
$1099
Market Cap:
$85.51B
Enzychem Lifesciences Corporation, a pharmaceutical company, focuses on the development of oral small molecule therapies for patients with unmet medical needs for oncology, metabolic diseases, and inflammatory diseases in South Korea. It is also developing potential therapies based on EC-18 technology platform to treat chemotherapy-induced neutropenia, chemoradiation therapy-induced oral mucositis, and acute radiation syndrome. The company was founded in 1999 and is headquartered in Seoul, South Korea.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-04-05
Stock Exchange
KOE
Ticker
183490.KQ
According to Enzychem Lifesciences Corporation’s latest financial reports and current stock price. The company's current ROE is -13.56%. This represents a change of 288.33% compared to the average of -3.49% of the last 4 quarters.
The mean historical ROE of Enzychem Lifesciences Corporation over the last ten years is -20.71%. The current -13.56% ROE has changed -34.51% with respect to the historical average. Over the past ten years (40 quarters), 183490.KQ's ROE was at its highest in in the June 2017 quarter at 0%. The ROE was at its lowest in in the March 2018 quarter at -25.83%.
Average
-20.71%
Median
-23.07%
Minimum
-37.32%
Maximum
-4.82%
Discovering the peaks and valleys of Enzychem Lifesciences Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 186.05%
Maximum Annual ROE = -4.82%
Minimum Annual Increase = -66.67%
Minimum Annual ROE = -37.32%
Year | ROE | Change |
---|---|---|
2024 | -13.79% | 186.05% |
2023 | -4.82% | -61.25% |
2022 | -12.44% | -66.67% |
2021 | -37.32% | 54.52% |
2020 | -24.15% | 5.95% |
2019 | -22.80% | -7.02% |
2018 | -24.52% | 6.28% |
2017 | -23.07% | -1.78% |
The current ROE of Enzychem Lifesciences Corporation (183490.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.35%
5-year avg
-18.50%
10-year avg
-20.71%
Enzychem Lifesciences Corporation’s ROE is greater than Genexine, Inc. (-27.40%), less than Green Cross Corporation (2.10%), greater than ABL Bio Inc. (-81.65%), less than Hanmi Pharm. Co., Ltd. (10.49%), less than ALTEOGEN Inc. (49.54%),
Company | ROE | Market cap |
---|---|---|
-27.40% | $226.03B | |
2.10% | $1.53T | |
-81.65% | $3.35T | |
10.49% | $3.59T | |
49.54% | $23.62T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enzychem Lifesciences Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Enzychem Lifesciences Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Enzychem Lifesciences Corporation's ROE?
How is the ROE calculated for Enzychem Lifesciences Corporation (183490.KQ)?
What is the highest ROE for Enzychem Lifesciences Corporation (183490.KQ)?
What is the 3-year average ROE for Enzychem Lifesciences Corporation (183490.KQ)?
What is the 5-year average ROE for Enzychem Lifesciences Corporation (183490.KQ)?
How does the current ROE for Enzychem Lifesciences Corporation (183490.KQ) compare to its historical average?